Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL567P is a non-coding RNA pseudogene derived from the 7SL RNA gene family. Canonically, 7SL RNA forms the RNA core of the signal recognition particle, which is critical for the cotranslational targeting of secretory and membrane proteins to the endoplasmic reticulum[3][1]. Pseudogenes such as RN7SL567P arise through gene duplication or retrotransposition but typically lack functional products due to disabling mutations[4]. While some pseudogenes may be transcribed and weakly regulate their parental gene by acting as microRNA sponges or sources of small interfering RNAs, no such role has been demonstrated for RN7SL567P. It is not considered a druggable or therapeutic target, nor does it function as a receptor, enzyme, transporter, or ion channel[4][2]. The majority of research on 7SL RNA pertains to the functional gene, not the pseudogenes. If you are searching for information about the therapeutic or biological relevance of 7SL RNA, refer to the canonical gene "Signal recognition particle 7SL RNA" (not the pseudogene). The pseudogene entry is primarily of genomic and evolutionary interest.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 567, pseudogene (RN7SL567P).